Skip to content
Search

Latest Stories

India approves country's first Covid vaccine

INDIA's drug regulator on Friday(1) approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources said.

The decision clears the vaccine's rollout in the world's second-most populous country which, after the US, has the highest number of Covid-19 infections.


India wants to start administering the vaccine soon, most likely by Wednesday(6), said one of the sources.

Britain and Argentina have already authorised the AstraZeneca vaccine for urgent public use.

The Central Drugs Standard Control Organization (CDSCO) is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech.

Cheaper and easier to distribute than rival shots, the AstraZeneca/Oxford vaccine could be a game-changer for global immunisation.

Countries with relatively basic health infrastructure have high hopes for a shot that, unlike Pfizer's, can be stored and transported under normal refrigeration, rather than supercooled to -70 degrees Celsius (-94 Fahrenheit).

India has reported more than 10 million Covid-19 cases, though its rate of infection has come down significantly from a mid-September peak. The country hopes to inoculate 300 million of its 1.35 billion people in the first six to eight months of 2021.

Britain became the first country this week to authorise the AstraZeneca vaccine, moving ahead of other western countries as it seeks to stem a record surge of infections driven by a highly contagious form of the virus that has also surfaced in India.

The AstraZeneca shot is being manufactured in India by Serum Institute of India (SII), the world's biggest producer of vaccines, which has already stockpiled about 50 million doses.

Though the Indian government has not yet signed a purchase agreement with SII, the company says it will focus on the home market first, and then exports - mainly to South Asian countries and Africa.

Questions about the degree of effectiveness of the AstraZeneca shot have surrounded it since data published in November showed a divergence in success rates, which the developers said reflected different dosing regimens.

Britain's medicines regulator further clouded the picture this week when it said that it had found an 80 per cent success rate when two full doses were administered, three months apart, higher than the average that the developers themselves had found.

More For You

5 best top coat nail polishes in the UK for 2025:  Shine, strength & chip-free nails

Seal the deal on a flawless manicure—top coat picks that keep your nails glossy, strong, and chip-free

iStock

5 best top coat nail polishes in the UK for 2025:  Shine, strength & chip-free nails

A flawless manicure isn’t just about picking the perfect shade—it’s about sealing the deal with a top coat that adds shine, extends wear, and keeps your nails looking salon-fresh. Whether you love a glossy gel-like finish, a quick-dry formula, or a little sparkle, we’ve rounded up the 5 best top coat nail polishes for 2025 that are making waves in the UK.

So, if you’re tired of chips, smudges, and dull nails, these game-changing top coats will take your mani from basic to breath-taking.

Keep ReadingShow less
Affordable gift ideas for Valentine’s Day

Love need not come with a hefty price tag

Affordable gift ideas for Valentine’s Day

THE ongoing credit crunch and cost of living crisis may pose a challenge for many this Valentine’s Day.

While extravagant gestures may be out of reach, that doesn’t mean the annual celebration of love has to feel any less special. There are plenty of thoughtful, creative, meaningful and romantic ways to make someone feel cherished – without breaking the bank.

Keep ReadingShow less
Dr Punam Krishan: ‘My book inspires children to appreciate their bodies’

Dr Punam Krishan

Dr Punam Krishan: ‘My book inspires children to appreciate their bodies’

AN ASIAN doctor said she wants children to feel excited and empowered about their bodies when they read her new book.

Published last month, Dr Punam Krishan’s You & Your Body helps children and families understand the human body and make positive choices about well-being, the author said.

Keep ReadingShow less
How Gen Z is shaping the future of work with 'micro-retirement'

Gen Z reimagines the future of work with micro-retirement, prioritizing well-being and life experiences

Getty Images

How Gen Z is shaping the future of work with 'micro-retirement'

Forget waiting until 60 to kick back and relax because the Gen Z is now rewriting the rulebook with micro-retirement. This trend is all about taking breaks during the hustle of your career, sometimes for months, to recharge, travel, or maybe dive into personal passions. It’s not just a long vacation but more like a shift in how work-life balance is seen, with mental health and experiences taking the lead.

What is micro-retirement?

Micro-retirement is exactly what it sounds like: stepping away from work for a planned, extended break during your prime years. Whether it’s exploring new hobbies, travelling the world, or simply resting, this pause is placed intentionally in the middle of a career and not at the end of it. Gen Z doesn’t want to wait for retirement to live fully rather it’s about making time for life now.


Gen Z redefines work-life balance with the rise of micro-retirement in their career journeyGetty Images

Keep ReadingShow less